XIGDUO XR 5 mg/1

Xigduo XR 5 mg/1 combines dapagliflozin and metformin hydrochloride for extended-release blood sugar management. This oral medication supports glucose control in adults with type 2 diabetes.

Xigduo XR 5 mg/1 is typically used to improve glycemic control in adults with type 2 diabetes. The combination of dapagliflozin and metformin hydrochloride works to lower blood sugar levels, which may help manage diabetes when diet and exercise alone are not sufficient. This medication is often prescribed as part of a comprehensive diabetes management plan.

Common effects of Xigduo XR 5 mg/1 may include gastrointestinal discomfort, such as nausea or diarrhea, particularly when first starting the medication. Some individuals may also experience increased urination due to the dapagliflozin component. These effects are generally mild and temporary, but persistent or severe symptoms should be discussed with a healthcare provider.

Xigduo XR 5 mg/1 should be handled with care, especially for individuals with kidney issues or a history of lactic acidosis. It is important to stay hydrated and monitor blood sugar levels regularly. This medication should be taken exactly as directed, and any changes in dosage should be discussed with a healthcare provider.

Xigduo XR 5 mg/1 may interact with certain medications, including those that affect kidney function or blood sugar levels. Alcohol and some over-the-counter drugs can also impact the effectiveness of this medication. It is advisable to consult a healthcare provider before starting any new medications while taking Xigduo XR 5 mg/1.